Guangzhou Zhongkebaishi's Hand Sanitizer Gel, labeled 75% ethanol, tested at 51% and was refused US import.
What happened
FDA laboratory testing of a batch of Hand Sanitizer Gel detained and refused admission at the US border found an average of 51% v/v ethanol, although the label stated 75%. FDA also said the product is an unapproved new drug and is misbranded (its labeling does not meet legal requirements), and FDA placed all drugs from the firm on Import Alert 66-78, which allows detention without physical examination. After a Nov. 2, 2020 teleconference and multiple requests, FDA said the firm gave inadequate or incomplete responses and did not provide requested test methods, analytical procedures, impurity testing, stability reports, or batch records.
What FDA found
The hand sanitizer labeled 75% ethanol contained only 51% ethanol on average, so its strength was below what the label claimed (adulterated).
FD&C Act section 501(c), 21 U.S.C. 351(c)FDA said the firm did not provide finished-product test methods, analytical procedures, impurity testing, stability reports, or batch records, so it could not assure identity, strength, quality, and purity under CGMP (current good manufacturing practice).
21 CFR 211.84 and 21 CFR 211.165; FD&C Act section 501(a)(2)(B), 21 U.S.C. 351(a)(2)(B)The product is an unapproved new drug because it is not generally recognized as safe and effective for its labeled use and has no FDA-approved application.
FD&C Act section 505(a), 21 U.S.C. 355(a); sections 301(d), 21 U.S.C. 331(d)The label is false or misleading because it states 75% ethanol when testing found far less, and it displays an FDA logo that suggests FDA approval.
FD&C Act section 502(a), 21 U.S.C. 352(a); 21 CFR 207.77(b)The Drug Facts label lacks required Active ingredient and Purpose headings, is not organized as required, and includes extra 'Properties & Functions' statements.
FD&C Act section 502(c), 21 U.S.C. 352(c); 21 CFR 201.66The label does not give a complete domestic address or telephone number for reporting serious adverse events, and the product does not meet the requirements for marketing under section 505G.
FD&C Act sections 502(x) and 502(ee), 21 U.S.C. 352(x), 352(ee)
What FDA wants
FDA asks the firm to respond in writing within 15 working days with what it has done to address violations and prevent recurrence. FDA also asks for a detailed investigation of the 51% ethanol batch, raw material suppliers, a list and reconciliation of US-shipped hand sanitizer batches, and complete batch records.
Who should pay attention
- brands that buy hand sanitizer from this manufacturer
- US importers and distributors of consumer antiseptics
- retailers and suppliers relying on ethanol content labels
This is a summary. Read the original letter on fda.gov.